GE HEALTHCARE TECHNOLOGY (GEHC) Fundamental Analysis & Valuation
NASDAQ:GEHC • US36266G1076
Current stock price
61.03 USD
+0.19 (+0.31%)
At close:
60.81 USD
-0.22 (-0.36%)
After Hours:
This GEHC fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.
1. GEHC Profitability Analysis
1.1 Basic Checks
- GEHC had positive earnings in the past year.
- GEHC had a positive operating cash flow in the past year.
- Each year in the past 5 years GEHC has been profitable.
- In the past 5 years GEHC always reported a positive cash flow from operatings.
1.2 Ratios
- Looking at the Return On Assets, with a value of 5.65%, GEHC belongs to the top of the industry, outperforming 81.82% of the companies in the same industry.
- With an excellent Return On Equity value of 20.09%, GEHC belongs to the best of the industry, outperforming 94.12% of the companies in the same industry.
- The Return On Invested Capital of GEHC (7.81%) is better than 82.35% of its industry peers.
- Measured over the past 3 years, the Average Return On Invested Capital for GEHC is in line with the industry average of 9.14%.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 5.65% | ||
| ROE | 20.09% | ||
| ROIC | 7.81% |
ROA(3y)5.31%
ROA(5y)6.29%
ROE(3y)21.03%
ROE(5y)19.41%
ROIC(3y)8.25%
ROIC(5y)9.14%
1.3 Margins
- With an excellent Profit Margin value of 10.11%, GEHC belongs to the best of the industry, outperforming 83.42% of the companies in the same industry.
- GEHC's Profit Margin has declined in the last couple of years.
- Looking at the Operating Margin, with a value of 13.40%, GEHC belongs to the top of the industry, outperforming 81.82% of the companies in the same industry.
- GEHC's Operating Margin has declined in the last couple of years.
- GEHC's Gross Margin of 39.98% is on the low side compared to the rest of the industry. GEHC is outperformed by 67.38% of its industry peers.
- GEHC's Gross Margin has been stable in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 13.4% | ||
| PM (TTM) | 10.11% | ||
| GM | 39.98% |
OM growth 3Y-0.87%
OM growth 5Y-3.3%
PM growth 3Y-1.1%
PM growth 5Y-34%
GM growth 3Y0.71%
GM growth 5Y0.28%
2. GEHC Health Analysis
2.1 Basic Checks
- With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), GEHC is creating some value.
- Compared to 1 year ago, GEHC has less shares outstanding
- Compared to 5 years ago, GEHC has more shares outstanding
- Compared to 1 year ago, GEHC has about the same debt to assets ratio.
2.2 Solvency
- Based on the Altman-Z score of 1.75, we must say that GEHC is in the distress zone and has some risk of bankruptcy.
- GEHC's Altman-Z score of 1.75 is in line compared to the rest of the industry. GEHC outperforms 55.62% of its industry peers.
- The Debt to FCF ratio of GEHC is 6.67, which is on the high side as it means it would take GEHC, 6.67 years of fcf income to pay off all of its debts.
- GEHC's Debt to FCF ratio of 6.67 is fine compared to the rest of the industry. GEHC outperforms 73.80% of its industry peers.
- A Debt/Equity ratio of 0.92 indicates that GEHC is somewhat dependend on debt financing.
- GEHC has a worse Debt to Equity ratio (0.92) than 75.94% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.92 | ||
| Debt/FCF | 6.67 | ||
| Altman-Z | 1.75 |
ROIC/WACC1
WACC7.83%
2.3 Liquidity
- GEHC has a Current Ratio of 1.37. This is a normal value and indicates that GEHC is financially healthy and should not expect problems in meeting its short term obligations.
- Looking at the Current ratio, with a value of 1.37, GEHC is doing worse than 81.82% of the companies in the same industry.
- GEHC has a Quick Ratio of 1.13. This is a normal value and indicates that GEHC is financially healthy and should not expect problems in meeting its short term obligations.
- The Quick ratio of GEHC (1.13) is worse than 77.01% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.37 | ||
| Quick Ratio | 1.13 |
3. GEHC Growth Analysis
3.1 Past
- The earnings per share for GEHC have decreased by -0.87% in the last year.
- GEHC shows a very negative growth in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -31.63% yearly.
- GEHC shows a small growth in Revenue. In the last year, the Revenue has grown by 4.84%.
- The Revenue has been growing slightly by 3.74% on average over the past years.
EPS 1Y (TTM)-0.87%
EPS 3Y2.54%
EPS 5Y-31.63%
EPS Q2Q%-1.98%
Revenue 1Y (TTM)4.84%
Revenue growth 3Y3.99%
Revenue growth 5Y3.74%
Sales Q2Q%7.41%
3.2 Future
- Based on estimates for the next years, GEHC will show a quite strong growth in Earnings Per Share. The EPS will grow by 8.20% on average per year.
- GEHC is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 4.24% yearly.
EPS Next Y12.83%
EPS Next 2Y11.38%
EPS Next 3Y11.08%
EPS Next 5Y8.2%
Revenue Next Year5.54%
Revenue Next 2Y4.99%
Revenue Next 3Y4.88%
Revenue Next 5Y4.24%
3.3 Evolution
- The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
- When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
4. GEHC Valuation Analysis
4.1 Price/Earnings Ratio
- The Price/Earnings ratio is 13.38, which indicates a correct valuation of GEHC.
- Based on the Price/Earnings ratio, GEHC is valued cheaper than 88.24% of the companies in the same industry.
- GEHC is valuated rather cheaply when we compare the Price/Earnings ratio to 26.64, which is the current average of the S&P500 Index.
- GEHC is valuated reasonably with a Price/Forward Earnings ratio of 10.74.
- Based on the Price/Forward Earnings ratio, GEHC is valued cheaply inside the industry as 93.58% of the companies are valued more expensively.
- The average S&P500 Price/Forward Earnings ratio is at 21.36. GEHC is valued slightly cheaper when compared to this.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 13.38 | ||
| Fwd PE | 10.74 |
4.2 Price Multiples
- GEHC's Enterprise Value to EBITDA ratio is rather cheap when compared to the industry. GEHC is cheaper than 90.91% of the companies in the same industry.
- Based on the Price/Free Cash Flow ratio, GEHC is valued cheaply inside the industry as 90.91% of the companies are valued more expensively.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 18.5 | ||
| EV/EBITDA | 10 |
4.3 Compensation for Growth
- GEHC's PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
- GEHC has a very decent profitability rating, which may justify a higher PE ratio.
PEG (NY)1.04
PEG (5Y)N/A
EPS Next 2Y11.38%
EPS Next 3Y11.08%
5. GEHC Dividend Analysis
5.1 Amount
- GEHC has a yearly dividend return of 0.23%, which is pretty low.
- In the last 3 months the price of GEHC has falen by -22.72%. A price decline artificially increases the dividend yield. It may be a sign investors do not expect the dividend to last.
- Compared to an average industry Dividend Yield of 0.26, GEHC pays a better dividend. On top of this GEHC pays more dividend than 89.84% of the companies listed in the same industry.
- With a Dividend Yield of 0.23, GEHC pays less dividend than the S&P500 average, which is at 1.80.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0.23% |
5.2 History
- GEHC has been paying a dividend for less than 5 years, so it still needs to build a track record.
Dividend Growth(5Y)N/A
Div Incr Years2
Div Non Decr Years2
5.3 Sustainability
- 3.07% of the earnings are spent on dividend by GEHC. This is a low number and sustainable payout ratio.
DP3.07%
EPS Next 2Y11.38%
EPS Next 3Y11.08%
GEHC Fundamentals: All Metrics, Ratios and Statistics
61.03
+0.19 (+0.31%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Industry Strength11.18
Industry Growth59.63
Earnings (Last)04-29 2026-04-29/bmo
Earnings (Next)07-27 2026-07-27
Inst Owners93.2%
Inst Owner Change-7.65%
Ins Owners0.35%
Ins Owner Change0.66%
Market Cap27.85B
Revenue(TTM)20.63B
Net Income(TTM)2.08B
Analysts78.57
Price Target93 (52.38%)
Short Float %2.67%
Short Ratio3.48
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0.23% |
Yearly Dividend0.14
Dividend Growth(5Y)N/A
DP3.07%
Div Incr Years2
Div Non Decr Years2
Ex-Date04-02 2026-04-02 (0.035)
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)0.4%
Min EPS beat(2)-0.16%
Max EPS beat(2)0.96%
EPS beat(4)3
Avg EPS beat(4)5.61%
Min EPS beat(4)-0.16%
Max EPS beat(4)13.24%
EPS beat(8)6
Avg EPS beat(8)4.83%
EPS beat(12)10
Avg EPS beat(12)5.31%
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-0.59%
Min Revenue beat(2)-0.75%
Max Revenue beat(2)-0.44%
Revenue beat(4)1
Avg Revenue beat(4)-0.46%
Min Revenue beat(4)-1.09%
Max Revenue beat(4)0.42%
Revenue beat(8)1
Avg Revenue beat(8)-1.72%
Revenue beat(12)2
Avg Revenue beat(12)-1.42%
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-2.08%
PT rev (3m)-0.59%
EPS NQ rev (1m)0.25%
EPS NQ rev (3m)5.2%
EPS NY rev (1m)-0.02%
EPS NY rev (3m)2.65%
Revenue NQ rev (1m)0.04%
Revenue NQ rev (3m)0.65%
Revenue NY rev (1m)0.05%
Revenue NY rev (3m)1.15%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 13.38 | ||
| Fwd PE | 10.74 | ||
| P/S | 1.35 | ||
| P/FCF | 18.5 | ||
| P/OCF | 14.01 | ||
| P/B | 2.68 | ||
| P/tB | N/A | ||
| EV/EBITDA | 10 |
EPS(TTM)4.56
EY7.47%
EPS(NY)5.68
Fwd EY9.31%
FCF(TTM)3.3
FCFY5.4%
OCF(TTM)4.35
OCFY7.14%
SpS45.2
BVpS22.75
TBVpS-9.29
PEG (NY)1.04
PEG (5Y)N/A
Graham Number48.3093 (-20.84%)
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 5.65% | ||
| ROE | 20.09% | ||
| ROCE | 9.94% | ||
| ROIC | 7.81% | ||
| ROICexc | 9.32% | ||
| ROICexgc | 25% | ||
| OM | 13.4% | ||
| PM (TTM) | 10.11% | ||
| GM | 39.98% | ||
| FCFM | 7.3% |
ROA(3y)5.31%
ROA(5y)6.29%
ROE(3y)21.03%
ROE(5y)19.41%
ROIC(3y)8.25%
ROIC(5y)9.14%
ROICexc(3y)9.48%
ROICexc(5y)10.1%
ROICexgc(3y)28.41%
ROICexgc(5y)36.05%
ROCE(3y)10.49%
ROCE(5y)11.63%
ROICexgc growth 3Y-16.74%
ROICexgc growth 5Y-17.72%
ROICexc growth 3Y-3.85%
ROICexc growth 5Y-6.16%
OM growth 3Y-0.87%
OM growth 5Y-3.3%
PM growth 3Y-1.1%
PM growth 5Y-34%
GM growth 3Y0.71%
GM growth 5Y0.28%
F-Score4
Asset Turnover0.56
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.92 | ||
| Debt/FCF | 6.67 | ||
| Debt/EBITDA | 2.85 | ||
| Cap/Depr | 83.39% | ||
| Cap/Sales | 2.34% | ||
| Interest Coverage | 5.29 | ||
| Cash Conversion | 59.47% | ||
| Profit Quality | 72.18% | ||
| Current Ratio | 1.37 | ||
| Quick Ratio | 1.13 | ||
| Altman-Z | 1.75 |
F-Score4
WACC7.83%
ROIC/WACC1
Cap/Depr(3y)71.99%
Cap/Depr(5y)60.92%
Cap/Sales(3y)2.12%
Cap/Sales(5y)1.89%
Profit Quality(3y)91.25%
Profit Quality(5y)85.67%
High Growth Momentum
Growth
EPS 1Y (TTM)-0.87%
EPS 3Y2.54%
EPS 5Y-31.63%
EPS Q2Q%-1.98%
EPS Next Y12.83%
EPS Next 2Y11.38%
EPS Next 3Y11.08%
EPS Next 5Y8.2%
Revenue 1Y (TTM)4.84%
Revenue growth 3Y3.99%
Revenue growth 5Y3.74%
Sales Q2Q%7.41%
Revenue Next Year5.54%
Revenue Next 2Y4.99%
Revenue Next 3Y4.88%
Revenue Next 5Y4.24%
EBIT growth 1Y5.26%
EBIT growth 3Y3.09%
EBIT growth 5Y0.31%
EBIT Next Year31.17%
EBIT Next 3Y14.85%
EBIT Next 5Y12.12%
FCF growth 1Y-2.9%
FCF growth 3Y-5.84%
FCF growth 5Y-8.6%
OCF growth 1Y1.85%
OCF growth 3Y-2.03%
OCF growth 5Y-5.37%
GE HEALTHCARE TECHNOLOGY / GEHC Fundamental Analysis FAQ
What is the fundamental rating for GEHC stock?
ChartMill assigns a fundamental rating of 5 / 10 to GEHC.
What is the valuation status for GEHC stock?
ChartMill assigns a valuation rating of 7 / 10 to GE HEALTHCARE TECHNOLOGY (GEHC). This can be considered as Undervalued.
Can you provide the profitability details for GE HEALTHCARE TECHNOLOGY?
GE HEALTHCARE TECHNOLOGY (GEHC) has a profitability rating of 7 / 10.
What are the PE and PB ratios of GE HEALTHCARE TECHNOLOGY (GEHC) stock?
The Price/Earnings (PE) ratio for GE HEALTHCARE TECHNOLOGY (GEHC) is 13.38 and the Price/Book (PB) ratio is 2.68.
What is the earnings growth outlook for GE HEALTHCARE TECHNOLOGY?
The Earnings per Share (EPS) of GE HEALTHCARE TECHNOLOGY (GEHC) is expected to grow by 12.83% in the next year.